Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial
NCT03121573
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Duloxetine
Sponsor
Taichung Veterans General Hospital